working

Sign up for free to access

Get access to the latest equity research in real-time from 12 commissioned providers.

Get access to the latest equity research in real-time from 12 commissioned providers.


Get Started
Already a member? Log in here

More Content

More Content

VNRX: Management's key financial goal for 2025 is to be cash neutral on a full year basis.

Companies: VOLITIONRX (VNRX:NYSE)VolitionRX Ltd (VNRX:ASE)

VolitionRx webinar: Breakthrough liquid biopsy method for cancer detection

Companies: VolitionRX Ltd

VNRX: Additional clinical papers & company webinars provide insights to Volition's progress. Nu.Q Discover biomarkers selected for clinical trial. Management continues to focus on signing licensing deals for Capture-PCR & Nu.Q NETs.

Companies: VOLITIONRX (VNRX:NYSE)VolitionRX Ltd (VNRX:ASE)

Executive Interview - VolitionRx

Companies: VolitionRX Ltd

VolitionRx - Termination of coverage

Companies: VOLITIONRX (VNRX:NYSE)VolitionRX Ltd (VNRX:ASE)

© Research Tree 2025

  • Apple Store
  • Play Store

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top